[September 26, 2016]

Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022 - Research and Markets

Research and Markets has announced the addition of the "Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for "Diabetes and Obesity Drugs". The market assessment is performed through standard and the tailored research methodology approach.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

• Market Sizing estimations an forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
• Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Regional and country level market analysis
• Competitive landscaping mapping the key common trends
• Company profiling covering the financials, recent activities and the future strategies
• Supply chain trends mapping the recent advancements
• Strategic recommendations for the new entrants

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Diabetes and Obesity Drugs Market by Product type

6 Diabetes and Obesity Drugs Market by Treatment

7 Geographical Segmentation

8 Vendor Landscaping

9 Company Profiles

• Eli Lilly
• Novo Nordisk
• Merck & Co
• Sanofi
• Takeda
• AstraZeneca
• Johnson & Johnson
• Novartis
• Becton, Dickinson and Company
• Arena Pharmaceuticals
• Orexigen Therapeutics, Inc.
• VIVUS, Inc.
• Biodel
• DexCom
• Insulet Corp
• Lexicon Pharma
• Medtronic
• vTv Thera
• Regenereon
• MannKind Corp

For more information about this report visit http://www.researchandmarkets.com/research/2hkdx6/global_diabetes

View source version on businesswire.com: http://www.businesswire.com/news/home/20160926005852/en/

[ Back To TMCnet.com's Homepage ]